A summary of the molecular testing recommended in acute myeloid leukemia
<p>Advances in Next-Generation Sequencing technologies (NGS) are revealing germline and somatic mutations that, together with karyotype, determine the diagnosis and subtype of Acute Myeloid Leukemia (AML). Molecular testing is also essential for the genetic risk stratification of patients with...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | 图书 |
| 出版: |
Annals of Molecular and Genetic Medicine - Peertechz Publications,
2020-04-18.
|
| 主题: | |
| 在线阅读: | Connect to this object online. |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|